# A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of AMG 403 in Healthy Subject

> **NCT02348879** · PHASE1 · COMPLETED · sponsor: **Amgen** · enrollment: 51 (actual)

## Conditions studied

- Chronic Pain

## Interventions

- **DRUG:** AMG 403
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02348879
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2006-01
- **Final completion:** 2006-03
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2015-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02348879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02348879, "A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of AMG 403 in Healthy Subject". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02348879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*